Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Read more...
 
The Next Takeover Target
RealBiz Media Group, Inc. is on the cutting edge of a fast-growing, high value digital media platform for the real estate industry. Based on recent transactions we believe RBIZ could emerge as the next takeover candidate in the space. Our target is $4.00.
Read more...
 
Multiple Indications Equals Tens of Billions in Market Size for Nuvilex, Inc.

Nuvilex, Inc. (OTCQB – NVLX) is no one-trick pony. The Company’s live-cell encapsulation drug delivery platform has already demonstrated that it can significantly improve the efficacy and safety results in mid-stage clinical trial studies in patients in advanced stages of pancreatic cancer. But, as the development progresses, it is not inconceivable that the size of the market for platform reaches the tens of billions worldwide. 

Read more...
 
NVLX: Another State Makes It Official

Late last week, Governor Martin O’Malley made it official. Following a public bill-signing ceremony, the State of Maryland will now become the 19th state in the Union to approve a medical marijuana program.

Read more...
 
NVLX: Broader Medical Marijuana Research Forges Ahead

Broader Medical Marijuana Research Forges Ahead

Read more...
 
Rising LED Lighting Leader

It is clear that FNRG is an underfollowed and relative unknown in the LED market. However, as the Company hits on some of what we believe could be nearly $100M in projects up for bid, the stock could quickly trade to the $9.00 level.

Read more...
 
NVLX and Other Oncology Stocks on Fire
NVLX & Other Small Cap Oncology Stocks on Fire Leading Up to ASCO Meeting
Read more...
 
Could FAB Move Like Netflix?

Following a review of FAB’s Libsyn subscriber numbers and Netflix’s (NASDAQ – NFLX) subscriber growth and valuation methodology we believe that a case can be made that FAB’s Libsyn division could be worth $150M or more.

Read more...
 
NVLX Worth at Least $0.30 Today
Following an exhaustive survey of anti-cancer biotechs, biopharmaceuticals, and medical marijuana companies, we believe that Nuvilex’s shares are worth as much as $0.30 per share--- today. That figure represents $0.15 for each of the Company’s two primary offerings alone.
Read more...
 
DUCP: Huge Potential Down Under

Leveraging the historical mining successes in the region and on the site itself, ARX Gold Corporation (OTCBB: DUCP) appears poised to take advantage of one of the most attractive mining opportunities in the industry.

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 Next > End >>

Page 31 of 37